Abstract | OBJECTIVE: STUDY DESIGN: A prospective feasibility study of 10 infants with HIE and 8 age-matched control subjects was undertaken. Following parental consent, blood samples were obtained at baseline before institution of TH (<6 h of life), during TH, at rewarming and post-TH in the HIE group with a baseline sample from the control group. GLUT1 and GLUT3 were measured by Enzyme-linked immunosorbent assay (ELISA) with brain biomarkers, Neuron-Specific Enolase (NSE) and Glial Fibrillary Acidic Protein (GFAP). Novel "HIE-high risk" and "Neurological" scores were developed to help identify HIE and to assess severity and prognosis, respectively. RESULTS: RBC GLUT1 concentrations were increased at the baseline pre-TH time point in HIE versus control subjects (p = .006), normalizing after TH (p = .05). An association between GLUT1 and NSE concentrations (which was reflective of the HIE-high risk and the Neuro-scores) in controls and HIE pre-TH was seen (R2 = 0.36, p = .008), with GLUT1 demonstrating 90% sensitivity and 88% specificity for presence of HIE identified by Sarnat Staging. WBC GLUT3 concentrations were low and no different in HIE versus control, and GFAP concentrations trended higher during re-warming (p = .11) and post-TH (p = .16). We demonstrated a significant difference between HIE and controls for both the "HIE-high risk" and the "Neurological" Scores. The latter score revealing the severity of clinical neurological illness correlated with the corresponding RBC GLUT1 (R2 value = 0.39; p = .006). CONCLUSION: Circulating RBC GLUT1 concentrations with NSE demonstrate a significant potential in reflecting the severity of HIE pre-TH and gauging effectiveness of TH. In contrast, the low neonatal WBC GLUT3 concentrations make discerning differences between degrees of HIE as well as assessing effectiveness of TH difficult. The HIE-high risk and Neurological scores may extend the "Sarnat staging" towards assessing severity and neuro-developmental prognosis of HIE.
|
Authors | Liesbeth V Maggiotto, Monica Sondhi, Bo-Chul Shin, Meena Garg, Sherin U Devaskar |
Journal | Molecular genetics and metabolism
(Mol Genet Metab)
Vol. 127
Issue 2
Pg. 166-173
(06 2019)
ISSN: 1096-7206 [Electronic] United States |
PMID | 31182397
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019. Published by Elsevier Inc. |
Chemical References |
- Biomarkers
- GFAP protein, human
- Glial Fibrillary Acidic Protein
- Glucose Transporter Type 1
- Glucose Transporter Type 3
- SLC2A1 protein, human
- SLC2A3 protein, human
- Phosphopyruvate Hydratase
|
Topics |
- Biomarkers
- Erythrocytes
(metabolism)
- Feasibility Studies
- Female
- Glial Fibrillary Acidic Protein
(metabolism)
- Glucose Transporter Type 1
(metabolism)
- Glucose Transporter Type 3
(metabolism)
- Humans
- Hypoxia-Ischemia, Brain
(diagnosis)
- Infant, Newborn
- Intensive Care Units, Neonatal
- Male
- Phosphopyruvate Hydratase
(metabolism)
- Pilot Projects
- Prognosis
- Prospective Studies
- Sensitivity and Specificity
- Severity of Illness Index
|